Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties
Authors:
- Dharmarajan SriramDSDharmarajan Sriram
- Tanushree Ratan BalTBTanushree Ratan Bal
- Perumal YogeeswariPYPerumal Yogeeswari
- 1 November 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (22) , 5865-5873
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Synthesis of Tetrahydro-2H-[1,3,5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activityScientia Pharmaceutica, 2004
- Towards the Design and Development of Agents with Broad Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV / AIDSCurrent Medicinal Chemistry, 2003
- Effect of Alpha Interferon on the Hepatitis C Virus RepliconJournal of Virology, 2001
- Novel Modifications in the Alkenyldiarylmethane (ADAM) Series of Non-Nucleoside Reverse Transcriptase InhibitorsJournal of Medicinal Chemistry, 1999
- Synthesis and Screening for Anti-HIV Activity of Some N-Mannich Bases of Isatin DerivativesChemotherapy, 1999
- Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infectionIl Farmaco, 1999
- Hepatitis CThe Lancet, 1998
- What can be Expected from Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections?Reviews in Medical Virology, 1996
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenNew England Journal of Medicine, 1981